
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Immunome
Deal Size : Undisclosed
Deal Type : Collaboration
Infinimmune Announces Research Collaboration with Immunome
Details : The collaboration aims for the discovery and optimization of novel antibodies using Infinimmune's GLIMPSE and Anthrobody platforms.
Product Name : Undisclosed
Product Type : Antibody, Unconjugated
Upfront Cash : Undisclosed
September 18, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Immunome
Deal Size : Undisclosed
Deal Type : Collaboration

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : IFX-101
Therapeutic Area : Dermatology
Study Phase : Preclinical
Recipient : KBI Biopharma
Deal Size : Undisclosed
Deal Type : Collaboration
KBI Biopharma Announces Collaboration with Infinimmune to Support Antibody Manufacturing
Details : The collaboration aims to advance manufacturing of Infinimmune’s lead human monoclonal antibody, IFX-101 program.
Product Name : Undisclosed
Product Type : Antibody, Unconjugated
Upfront Cash : Undisclosed
September 08, 2025
Lead Product(s) : IFX-101
Therapeutic Area : Dermatology
Highest Development Status : Preclinical
Recipient : KBI Biopharma
Deal Size : Undisclosed
Deal Type : Collaboration

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Grid Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
Details : Under the partnership, Grid will identify new antibody drug candidates for non-small cell lung cancer, by leveraging Infinimmune’s Anthrobody™ drug discovery platform.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 19, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Grid Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery
Sponsor : Playground Global
Deal Size : $12.0 million
Deal Type : Financing
Details : Infinimmune is reinventing antibody drug discovery by focusing solely on human-derived antibody drugs. Inside every human, the equivalent of 100 billion antibody clinical trials are conducted every day, testing each antibody for safety and efficacy in pa...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 07, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery
Sponsor : Playground Global
Deal Size : $12.0 million
Deal Type : Financing
